Fig. 4
From: Antibody-drug conjugates in breast cancer: current evidence and future directions
Future directions of ADCs in breast cancer. ADC, antibody–drug conjugate; HER2, human epidermal growth factor receptor 2; TROP2, trophoblast cell surface antigen-2; ILD, interstitial lung disease; PD-(L)1, programmed death-1/programmed death-ligand 1. Created in BioRender. Li, N. (2025) https://BioRender.com/t70c288